3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
18
INDUSTRY
6
OTHER_GOV
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Neoplasms
4
Lung Neoplasms
3
Uterine Cervical Neoplasms
2
Small Cell Lung Carcinoma
2
Rectal Neoplasms
2
Esophageal Neoplasms
2
Colorectal Neoplasms
2
Breast Neoplasms
2
Unresectable Non-small Cell Lung Cancer
1
Tobacco Use Cessation
1
Recurrence
1
Rectal Diseases
1
Pancreatic Cancer Liver Metastases
1
Ovarian Neoplasms
1
Ototoxicity
1
Neoplasms, Second Primary
1
Neoplasms by Site
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Mouth Neoplasms
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Intestinal Neoplasms
1
Intestinal Diseases
1
Hodgkin Disease
1
Hearing Loss
1
HER2 Positive Metastatic Breast Cancer
1
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Interventions
Surgical Procedures, Operative
2
Dexamethasone
2
temoporfin
1
pomalidomide
1
pembrolizumab
1
nimotuzumab
1
liposomal doxorubicin
1
ledipasvir
1
ibrutinib
1
golimumab
1
Vinorelbine
1
Tomography, X-Ray Computed
1
Thalidomide
1
Sofosbuvir
1
Rituximab
1
Ribavirin
1
Radiotherapy
1
Radiation
1
Paclitaxel
1
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
1
Mitoxantrone
1
Mastectomy
1
Irinotecan
1
Infliximab
1
Immunotherapy, Adoptive
1
Hematologic Tests
1
Drug Therapy
1
Docetaxel
1
Diagnostic Imaging
1
Dermoscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Recurrence
×
Drug Therapy
×
Clear all
NCT06670911
2025-02-24
ACCESS-I
Instituto Nacional de Cancer, Brazil
Phase 2
Recruiting
44 enrolled